Trajenta®

linagliptin

About Trajenta®

Treatment of type 2 diabetes mellitus to improve glycaemic control in adults, used in monotherapy (if metformin is not tolerated or contraindicated) or in combination therapy.

 

Professional Area

You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.

Product Key Facts

Indications

Type 2 diabetes mellitus 

Brand Names

Trajenta® Tradjenta® Trazenta® Trayenta®

Active ingredients

linagliptin